Clinical Trials Logo

Clinical Trial Summary

This is an historic cohort study based on the birth and delivery register of the HFME maternity ward. This study aim at understanding the evolution of asphyxia at birth, at all gestational ages, identifying causes and describing neonatal outcomes since 2000, when a second line strategy for foetal surveillance (fetal ECG) and systematic umbilical acid-gas cord blood were introduced in our maternity ward.

The investigator's hypothesis was that the neonatal asphyxia decrease could be due to 3 main factors including second line strategy introduction, systematic umbilical cord acid-base implementation and improvement in antenatal risk factor screening for asphyxia. The investigator's second hypothesis was that neonatal prognosis in neonates with acidosis was improved with systematic early after birth EEG evaluation, allowing early treatment and surveillance.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03227536
Study type Observational
Source Hospices Civils de Lyon
Contact
Status Completed
Phase N/A
Start date January 2017
Completion date July 2017

See also
  Status Clinical Trial Phase
Recruiting NCT05514340 - Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy Phase 2
Not yet recruiting NCT06377098 - Intrapartum Sildenafil in Laboring Mothers Phase 2
Recruiting NCT04369313 - Effect of DCC on Neonatal Jaundice and Blood Gas Analysis in Infants Born to GDM Mothers N/A
Completed NCT03254628 - Saving Lives at Birth in Uganda: Building and Sustaining Capacity of Frontline Health Workers - A Program Evaluation N/A
Completed NCT06429111 - Effectiveness and Safety in Maternal and Neonatal Outcomes in Water Birth.
Completed NCT02347241 - Infant Special Program for In Hospital Resuscitation Education in the Delivery Room N/A
Completed NCT03210194 - Randomized Cluster Trial on Innovative and Standard Strategies for Neonatal Resuscitation Training (RCPNEOPERU Project) N/A